Still, with proven results, its clear why GLP-1 medications are being viewed as a significant breakthrough for people dealing with obesity and struggling with weight loss
Data from Indias ICMR-INDIAB study (2023) highlights that metabolic disorders including diabetes, hypertension, and dyslipidemia frequently co-exist in obese Indian adults making comprehensive screening even more critical before initiating any pharmacological weight loss treatment
What clinical trials show Large-scale clinical trials have measured average weight loss across thousands of participants: Wegovy (semaglutide 2.4 mg) : Participants in the STEP 1 trial lost an average of 14.9% of their body weight over 68 weeks
Is compounded GLP-1 always cheaper than brand
How serious athletes and weekend warriors actually use IV therapy for recovery: hydration, amino acids, antioxidants, and timing around training
GHK-Cu (3 aa plus copper) with copper transport and gene-expression modulation